The effect of the degree of deacetylation of chitosan nanoparticles and its characterization and encapsulation efficiency on drug delivery

Polymer - Plastics Technology and Engineering

Volumn 49, Issue 12, 2010, Pages 1292-1296

  Yang, Hui Chia ^a   Hon, Min Hsiung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Chitosan; Degree of deacetylation; Fluorouracil; Nanoparticle

Indexed keywords

CHITOSAN NANOPARTICLES; DEGREE OF DEACETYLATION; DRUG LOADING; ENCAPSULATION EFFICIENCY; FLUOROURACIL; FTIR AND NMR SPECTROSCOPY; MEAN PARTICLE SIZE;

ACETYLATION; CHITOSAN; DRUG DELIVERY; ENCAPSULATION; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CHITIN;

EID: 77956712490     PISSN: 03602559     EISSN: 15256111     Source Type: Journal    
DOI: 10.1080/03602559.2010.482076     Document Type: Article

References (22)

1. Heidelberger, C.; Ansfield, F.J. Experimental and clinical use of fluorinated pyrimidines in cancer chemotherapy. Cancer Res. 1963, 23, 1226-1243.
2. Shah, A.; MacDonald, W.; Goldie, J.; Gudauskas, G.; Brisebois, B. 5-FU infusion in advanced colorectal cancer: Comparison of three dose schedules. Cancer Treat Rev. 1985, 69, 739-742.
3. Caballero, G.A.; Ausma, R.K.; Quebbema, E.J. Long-term, ambulatory, continuous infusion of 5-FU for the treatment of advanced adenocarcinoma. Cancer Treat. Rev. 1985, 69, 13-16.
4. Flentje, M.; Flentje, D.; Schlag, P. Comparison of 5-FU versus FUDR activity in human colorectal cancer using an in vitro clonogenic assay (HTCA). Cancer Chemoth. Pharm. 1986, 18, 223-225.
5. Kimura, Y.; Okuda, H. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Jpn. J. Cancer Res. 1999, 90, 765-774.
6. Polk, A.; Amsden, B.; Yao, K.D.; Peng, T.; Goosen, F.A. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharmacol. Sci. 1994, 83, 178-185.
7. Liu, L.-S.; Liu, S.-Q.; Ng, S.Y.; Froix, M.; Ohno, T.; Heller, J. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J. Control. Rel. 1997, 43, 65-74.
8. Kawashina, Y.; Handa, T.; Takenaka, H.; Lin, S.Y.; Ando, Y. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphatechitosan. J. Pharm. Sci. 1985, 74, 264-268.
9. Shirashi, S.; Imai, T.; Otagiri, M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: Optimization and in vivo/in vitro evaluation. J. Control. Rel. 1993, 25, 217-225.
10. Sezer, A.D.; Akbuǧa, J. Controlled release of piroxicam from chitosan beads. Int. J. Pharm. 1995, 121, 113-116.
11. Aydin, Z.; Akbuǧa, J. Chitosan bead for the delivery of salmon calcitonin: Preparation and release characteristics. Int. J. Pharm. 1996, 131, 101-103.
12. Calvo, P.; Remuñãn-Lóez, C.; Vila-Jata, J.L.; Alonso, M.J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for protein and vaccines. Pharm. Res. 1997, 14, 1431-1436.
13. Aral, C.; Akbuǧa, J. Alternative approach to the preparation of chitosan beads. Int. J. Pharm. 1998, 168, 9-15.
14. Yang, H.C.; Hon, M.H. The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery. Microchem. J. 2009, 92, 87-91
15. Blanco, M.D.; Alonso, M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur. J. Pharm. Biopharm. 1997, 43, 287-294.
16. Bozkir, A.; Saka, O.M. Chitosan nanoparticles for plasmid DNA delivery: Effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv. 2004, 11, 107-112.
17. Scholes, P.D.; Coombes, A.G.A.; Illum, L.; Davis, S.S.; Vert, M., Davies, M.C. The preparation of sub-200nm poly(lactide-coglycolide) microspheres for site-specifique drug delivery. J. Control. Rel. 1993, 25, 145-153.
18. Harashima, H.; Sakata, K.; Funato, K.; Kiwada, H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 1994, 11, 402-406.
19. Bozkir, A.; Saka, O.M. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Il Farmaco 2005, 60, 840-846.
20. Mi, F.L.; Shyu, S.S.; Kuan, C.Y.; Lee, S.T.; Lu, K.T.; Jang, S.F. Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. I. Effect of phosphorous polyelectrolyte complex and enzymatic hydrolysis of polymer. Appl. Polym. Sci. 1999, 74, 1868-1879.
21. Knaul, J.Z.; Hudson, S.M.; Creber, K.A.M. Improved mechanical roperties of chitosan fibers. J. Appl. Polym. Sci. 1999, 72, 1721-1731.
22. Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. Recent dvances on chitosan-based micro- and nanoparticles in drug delivery. Control. Rel. 2004, 100, 5-28.